Showing 20,261 - 20,280 results of 226,077 for search '(( 5 ((ppm decrease) OR (mean decrease)) ) OR ( a ((point decrease) OR (a decrease)) ))', query time: 1.80s Refine Results
  1. 20261
  2. 20262
  3. 20263

    Expression of UCP1 is decreased in <i>Cfl2</i> deficient mice. by Sarah U. Morton (721345)

    Published 2015
    “…Western blot for Tubulin and GAPDH did not demonstrate any differences in expression, as a control for protein loading. Densitometry was used to demonstrate this quantitatively, with statistically significant decreases of UCP1 seen in <i>cofilin</i>-2 deficient mice compared to wild-type littermates when normalized to either GAPDH (left bars) or Tubulin (right bars). …”
  4. 20264
  5. 20265
  6. 20266
  7. 20267

    EMMPRIN siRNA significantly decreased the proliferation and invasion activities of 786-O. by Mototaka Sato (461331)

    Published 2013
    “…<div><p>(A) MTS assay (at 24, 48, and 72 h) was performed after EMMPRIN knockdown in 786-O cells. …”
  8. 20268
  9. 20269
  10. 20270
  11. 20271
  12. 20272
  13. 20273
  14. 20274
  15. 20275
  16. 20276

    Chronic hyperoxia decreases relaxant response to acetylcholine in intrapulmonary arteries of newborn rats. by Eric Dumas de la Roque (3779935)

    Published 2017
    “…<p>(A) Arterial relaxant response to acetylcholine was significantly decreased by hyperoxia (<i>n</i> = 8 vessels from 3 animals) compared with normoxia (<i>n</i> = 15 vessels from 5 animals). …”
  17. 20277

    Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-5 by John H Boyd (88940)

    Published 2011
    “…Activated cardiomyocytes incubated with fibrinogen alone demonstrate a 40% reduction in contractility. Pre-incubation of fibrinogen with the ICAM-1 (8–22) peptide results in competition between cardiomyocyte-expressed ICAM-1 and the ICAM-1 (8–22) peptide for the fibrinogen active site (117–133). …”
  18. 20278

    TM4SF18-silencing decreases pancreatic cancer cell growth. by Megha Singhal (6494645)

    Published 2019
    “…B) Colorimetric MTT assay showing a decrease in cell viability in response to five days post-induction of TM4SF18 shRNA or control shRNA. …”
  19. 20279
  20. 20280